This inventor holds 2 USPTO granted patents. Top assignees: Protherics Molecular Design Limited, Tularik Limited. Active years: 2001-2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001-2002
Title: Andrew Philip Austin Crew: Innovator in Serine Protease Inhibitors
Introduction
Andrew Philip Austin Crew is a notable inventor based in Congleton, Great Britain. He has made significant contributions to the field of medicinal chemistry, particularly in the development of serine protease inhibitors. With a total of two patents to his name, Crew's work has implications for various therapeutic applications.
Latest Patents
His latest patents include the innovative "1-amino-7-isoquinoline derivatives as serine protease inhibitors." This invention showcases his expertise in creating compounds that can potentially inhibit serine proteases, which are crucial in many biological processes and diseases.
Career Highlights
Throughout his career, Crew has worked with prominent companies such as Protherics Molecular Design Limited and Tularik Limited. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in drug development.
Collaborations
Crew has collaborated with esteemed colleagues, including John Walter Liebeschuetz and William Alexander Wylie. These partnerships have further enhanced his research capabilities and broadened the impact of his inventions.
Conclusion
Andrew Philip Austin Crew is a distinguished inventor whose work in serine protease inhibitors has the potential to advance therapeutic strategies. His contributions to medicinal chemistry are noteworthy and reflect his dedication to innovation in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile